Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 20/20 | 0.72 |
| ▸ | GNA15 | P30679 | 1/20 | 0.68 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.68 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.68 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.68 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16123789 | 0.93 | FFAR1 (0.73) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL13110490 | 0.92 | FFAR1 (0.85) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL13110442 | 0.92 | FFAR1 (0.82) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL13110495 | 0.90 | FFAR1 (0.85) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL13110447 | 0.90 | FFAR1 (0.83) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL15125747 | 0.90 | FFAR1 (0.74) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL16123744 | 0.90 | FFAR1 (0.74) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL764246 | 0.89 | FFAR1 (0.70) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL2688865 | 0.89 | FFAR1 (0.70) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL2690226 | 0.89 | FFAR1 (0.85) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014146604-A1 | FUSED RING COMPOUND HAVING GPR40 RECEPTOR FUNCTION REGULATING ACTION | 正大天晴药业集团股份有限公司 (CN) | 2014-09-25 | — | — | WO | disclosed |